ArticleBioinformatics advances2026
CORTADO: hill climbing optimization for cell-type specific marker gene discovery and clustering accuracy improvement.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- RKMR: A Rapid Kernel Machine Regression Framework for Optimal Marker Detection in Spatial Omics Data.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: The advent of single-cell RNA sequencing (scRNA-seq) has enhanced our ability to study cellular heterogeneity. Accurately identifying distinct subpopulations and their defining markers is critical for understanding tissue diversity. We introduce CORTADO, a hill-climbing optimization framework for marker discovery and clustering refinement. Results: CORTADO maximizes differential expression, minimizes redundancy via cosine similarity, and enforces sparsity for interpretability. By using CORTADO-selected markers to inform the cell-type identification process, an iterative refinement approach markedly increases the Adjusted Rand Index (ARI), a metric that quantifies how well the clustering assignments align with gold-standard cell-type annotations. Benchmarking across brain, immune, spatial, and cancer datasets confirms that CORTADO delivers biologically relevant markers and consistently outperforms state-of-the-art methods in both marker discovery and clustering accuracy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.